BACKGROUND The prevalence of dyslipidemia is increasing in many parts of Brazil, but it is yet unclear how much exercise is needed to attain beneficial effects on plasma lipoprotein levels. OBJECTIVE The study analyzed eight cities of the state of São Paulo, the association between the continued practice of physical exercise throughout life and the occurrence of dyslipidemia in adulthood. M...

Elevated free thyroxine (FT4) levels may play a protective role in development of dyslipidemia. However, few prospective studies have been performed to definite the effects of thyroid hormones on the improvement of dyslipidemia and its components. Thus, this study aims to clarify the association between thyroid hormones within normal range and reversal of dyslipidemia in the absence of interven...

Objectives We aimed to investigate the prevalence of dyslipidemia in patients with osteoarthritis (OA) and whether OA and dyslipidemia are associated. Methods We performed a systematic literature review and a meta-analysis, including cross-sectional, cohort and case-control studies, to assess the number of patients with OA and/or dyslipidemia. We calculated the mean (±SD) prevalence of dyslip...

BACKGROUND Dyslipidemia has been noted to play an integral role in the pathogenesis and progression of micro and macrovascular complications in diabetes mellitus patients. The complications exemplified by renal vascular and cardiovascular disease cause the most morbidity and mortality in this group of patients. OBJECTIVE This study is aimed at understanding the pattern of dyslipidemia among t...

background : various studies have indicated that dyslipidemia starts in childhood. there is a relationship between the concentration of blood lipids and atherosclerosis. in this study, we assessed the prevalence of dyslipidemia in elementary school children. methods: this cross-sectional study was performed on 1,626 (882 girls and 744 boys) elementary school children aged between 6 and 11 years...

Article history: Received on: 09/12/2015 Revised on: 22/01/2016 Accepted on: 08/02/2016 Available online: 30/04/2016 Dyslipidemia is a common complication of renal transplantation referred to as new onset dyslipidemia. Immune suppressants, in particular cyclosporine, the calcineurin inhibitor and others are known to cause dyslipidemia through non-competitive inhibition of sterol 27-dehydroxylas...

BACKGROUND The most recent Canadian population-level data on lipid levels are from 1992. This study presents current estimates of Canadians with dyslipidemia, the proportion aware of their condition, and the proportion being treated and below target values. METHODS The Canadian Health Measures Survey (2007-2009) assessed the prevalence, awareness and treatment of dyslipidemia. Dyslipidemia wa...

Dyslipidemia is a biochemical alteration connected to the pathology accompanying COVID-19 infection. has been recognized as common complication in infection exerting significant effect on severity and mortality infected patients. Disturbance of lipid profile cases diverse shown have various presentations. Inflammatory markers acute phase reactants were found relation with disrupted during Lipid...